Latest News about Alzheimer's disease
Recent news which mentions Alzheimer's disease
AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial
February 15, 2022
From Benzinga
Cortexyme Stock Plunges On FDA Hold On Atuzaginstat's IND
January 26, 2022
Tickers
CRTX
From Benzinga
FDA Places Clinical Hold On Denali's Alzheimer's Potential Program
January 13, 2022
Tickers
DNLI
From Benzinga
From Benzinga
Why Biogen's Alzheimer's drug Aduhelm is so controversial
January 04, 2022
From CNBC.com News
Acadia Slims Nuplazid Label Expansion Application For Alzheimer's Disease Psychosis
December 21, 2021
Tickers
ACAD
From Benzinga
After Much Criticism, Biogen Slashes Aduhelm Price In Half
December 20, 2021
Tickers
BIIB
From Benzinga
Alzamend Neuro Shares Are Trading Higher After Encourage Early-Stage Data From Alzheimer's Candidate
December 17, 2021
Tickers
ALZN
From Benzinga
EMA's Committee Gives Thumbs Down To Biogen's Controversial Alzheimer's Drug, As Expected
December 17, 2021
Tickers
BIIB
From Benzinga
From Benzinga
Thanksgiving Left-Overs 2021
November 30, 2021
From Stock Gumshoe
Waiting to talk finance with an aging parent in cognitive decline is a mistake, experts say
November 30, 2021
From CNBC.com News
European Regulator Votes Down Biogen's Alzheimer's Drug
November 17, 2021
Tickers
BIIB
From Benzinga
Why Are Biogen Shares Gaining Today?
November 12, 2021
From Benzinga
Eisai Posts New Lecanemab Data From Mid-Stage Alzheimer's Trial
November 11, 2021
From Benzinga
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
November 10, 2021
From Benzinga
Roche's Alzheimer's Candidate Secures FDA Breakthrough Designation
October 08, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.